NO20003629L - Forbindelser med veksthormonfrigjørende egenskaper - Google Patents

Forbindelser med veksthormonfrigjørende egenskaper

Info

Publication number
NO20003629L
NO20003629L NO20003629A NO20003629A NO20003629L NO 20003629 L NO20003629 L NO 20003629L NO 20003629 A NO20003629 A NO 20003629A NO 20003629 A NO20003629 A NO 20003629A NO 20003629 L NO20003629 L NO 20003629L
Authority
NO
Norway
Prior art keywords
compounds
growth hormone
hormone releasing
releasing properties
properties
Prior art date
Application number
NO20003629A
Other languages
English (en)
Other versions
NO20003629D0 (no
Inventor
Michael Ankersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20003629D0 publication Critical patent/NO20003629D0/no
Publication of NO20003629L publication Critical patent/NO20003629L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
NO20003629A 1998-01-16 2000-07-14 Forbindelser med veksthormonfrigjørende egenskaper NO20003629L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK5698 1998-01-16
DK79998 1998-06-15
PCT/DK1999/000021 WO1999036431A1 (en) 1998-01-16 1999-01-15 Compounds with growth hormone releasing properties

Publications (2)

Publication Number Publication Date
NO20003629D0 NO20003629D0 (no) 2000-07-14
NO20003629L true NO20003629L (no) 2000-09-15

Family

ID=26063207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003629A NO20003629L (no) 1998-01-16 2000-07-14 Forbindelser med veksthormonfrigjørende egenskaper

Country Status (15)

Country Link
EP (2) EP1506969B1 (no)
JP (1) JP4382279B2 (no)
KR (1) KR20010034198A (no)
CN (1) CN1288467A (no)
AT (2) ATE470671T1 (no)
AU (1) AU766305B2 (no)
BR (1) BR9906975A (no)
CA (1) CA2318558A1 (no)
DE (1) DE69921611T2 (no)
HU (1) HUP0100777A3 (no)
IL (1) IL137007A0 (no)
NO (1) NO20003629L (no)
PL (1) PL341707A1 (no)
TW (1) TW589325B (no)
WO (1) WO1999036431A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111461A1 (en) 1999-05-21 2002-08-15 Todd C. Somers Low molecular weight peptidomimetic growth hormone secretagogues
UA73530C2 (uk) 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
JP5122950B2 (ja) * 2004-06-29 2013-01-16 ヘルシン セラピューティクス(ユー.エス.),インコーポレイティド (3r)−1−(2−メチルアラニル−d−トリプトフィル)−3−(フェニルメチル)−3−ピペリジンカルボン酸1,2,2−トリメチルヒドラジドの結晶形
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
BRPI0807046A2 (pt) 2007-02-09 2015-05-26 Tranzyme Pharma Inc Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit.
CN108129357B (zh) * 2016-12-01 2021-12-21 上海医药工业研究院 阿拉莫林中间体的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
WO1983002272A1 (en) 1981-12-28 1983-07-07 Beckman Instruments Inc Synthetic peptides having pituitary growth hormone releasing activity
US4839344A (en) 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
AU633003B2 (en) 1988-05-11 1993-01-21 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
IT1240643B (it) 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
IL98910A0 (en) 1990-07-24 1992-07-15 Polygen Holding Corp Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
WO1995014666A1 (en) 1993-11-24 1995-06-01 Merck & Co., Inc. Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
WO1995017423A1 (en) 1993-12-23 1995-06-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
CA2179598A1 (en) 1993-12-23 1995-06-29 Nils Langeland Johansen Compounds with growth hormone releasing properties
WO1995034311A1 (en) 1994-06-13 1995-12-21 Merck & Co., Inc. Piperazine compounds promote release of growth hormone
WO1996002530A1 (en) 1994-07-20 1996-02-01 Merck & Co., Inc. Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
US5767118A (en) 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
US5798337A (en) 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
IL116923A (en) 1995-01-27 2000-09-28 Novo Nordisk As Compounds with growth hormone releasing properties and pharmaceutical compositions containing them
US5559128A (en) 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
WO1996035713A1 (en) 1995-05-08 1996-11-14 Pfizer, Inc. Dipeptides which promote release of growth hormone
DE69533991T2 (de) 1995-05-29 2006-04-13 Pfizer Inc. Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
HUP9802821A3 (en) 1995-06-22 2000-03-28 Novo Nordisk As Compounds with growth hormone releasing properties
AU6772996A (en) 1995-08-21 1997-03-12 Eli Lilly And Company 2-acylaminopropanamides as growth hormone secretagogues
WO1997007117A1 (en) 1995-08-21 1997-02-27 Eli Lilly And Company 2-acylaminopropanamines as growth hormone secretagogues
EP0766966A3 (en) 1995-09-08 2001-02-28 Eli Lilly And Company Method of treating insulin resistance
AU7169696A (en) 1995-09-26 1997-04-17 Merck & Co., Inc. 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone
IT1277113B1 (it) 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
PL327227A1 (en) * 1995-12-22 1998-12-07 Novo Nordisk As Compounds exhibiting growth hormone liberating properties
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
AU7906998A (en) * 1997-06-20 1999-01-04 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
DE69921611D1 (de) 2004-12-09
CN1288467A (zh) 2001-03-21
EP1506969B1 (en) 2010-06-09
AU766305B2 (en) 2003-10-16
WO1999036431A9 (en) 2000-07-27
TW589325B (en) 2004-06-01
NO20003629D0 (no) 2000-07-14
EP1047709A1 (en) 2000-11-02
HUP0100777A3 (en) 2001-12-28
EP1506969A1 (en) 2005-02-16
JP4382279B2 (ja) 2009-12-09
IL137007A0 (en) 2001-06-14
BR9906975A (pt) 2000-10-17
CA2318558A1 (en) 1999-07-22
AU2046599A (en) 1999-08-02
PL341707A1 (en) 2001-04-23
ATE281467T1 (de) 2004-11-15
DE69921611T2 (de) 2005-11-03
EP1047709B1 (en) 2004-11-03
HUP0100777A2 (hu) 2001-08-28
KR20010034198A (ko) 2001-04-25
WO1999036431A1 (en) 1999-07-22
ATE470671T1 (de) 2010-06-15
JP2002509156A (ja) 2002-03-26

Similar Documents

Publication Publication Date Title
SE9900100D0 (sv) New compounds
ATE248837T1 (de) Chinuclidin-acrylamide
BG106586A (en) Pyrazolopyramidines as therapeutic agents
DE69915063D1 (de) Aminocyclohexylverbindungen und deren verwendung
DE69725825D1 (de) 5-HT1F-Agonisten
DE69623899T2 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
PT1169337E (pt) Nitratos esteroides para o tratamento de lesoes oxidativas e disfuncoes endoteliais
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
ATE223386T1 (de) Benzimidazol-derivate und ihre verwendung als corticotropin freisetzenden faktor antagonisten
ATE231131T1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
NO20003629D0 (no) Forbindelser med veksthormonfrigjørende egenskaper
TW287103B (no)
NO20006699L (no) Forbindelser med veksthormonfrigjörende egenskaper
ID25478A (id) Agonis 5-ht1f
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
PT1027891E (pt) Antagonista de neuropeptido y
ES2160093A1 (es) Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
NO20012169D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
IL164536A0 (en) The use of hydroxypyridone-derivatives in wound healing

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application